Form 4 for PCVX Vaxcyte, Inc.
Accepted 2022-10-28 00:00:00 ET · period of report 2022-10-26 · accession 0001209191-22-054858 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-10-28 | 2022-10-26 | PCVX | Fairman Jeff | VP, Research | S - Sale | $40.00 | -10.0K | 286.2K | -3% | -$400.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-26 | S | D | 10,000 | $40.00 | 286,227 | I By Fairman Family Trust | — | — |